In addition, the CASC2 gene expression decreased dramatically with rising tumor grade, and the authors concluded that lncRNA ADAMTS9-AS2, HOXA11-AS, and CASC2 are potential biomarkers for glioma prognosis (70). Here, CASC2 is linked to central nervous system cancer.